Yuichi Sumii to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications Yuichi Sumii has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
1.049
-
Hematopoietic stem cell-derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide. JCI Insight. 2023 04 24; 8(8).
Score: 0.441
-
Successful haematopoietic progenitor cell collection by plerixafor in combination with reduced dose granulocyte colony-stimulating factor for severe hypoxemia provoked by high-dose granulocyte colony-stimulating factor administration. Transfus Med. 2022 12; 32(6):527-529.
Score: 0.106
-
Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation. Front Immunol. 2022; 13:891925.
Score: 0.105
-
Donor Treg expansion by liposomal a-galactosylceramide modulates Tfh cells and prevents sclerodermatous chronic graft-versus-host disease. Immun Inflamm Dis. 2021 09; 9(3):721-733.
Score: 0.096
-
Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab. Leukemia. 2021 03; 35(3):929-931.
Score: 0.095
-
Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease. Bone Marrow Transplant. 2021 04; 56(4):956-959.
Score: 0.093
-
Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient. Int J Hematol. 2020 Dec; 112(6):871-877.
Score: 0.092
-
Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy. Int J Hematol. 2020 Sep; 112(3):422-426.
Score: 0.022